key: cord-0325777-vgzbkxe5
authors: Garcia-Ptacek, S.; Xu, H.; Annetorp, M.; Back Jerlardtz, V.; Cederholm, T.; Engstrom, M.; Kivipelto, M.; Lundberg, L. G.; Metzner, C.; Olsson, M.; Skogo Nyvang, J.; Suhl Oberg, C.; Akesson, E.; Religa, D.; Eriksdotter, M.
title: Temporal trends in hospitalizations and 30-day mortality in older patients during the COVID pandemic from March 2020 to July 2021
date: 2021-12-27
journal: nan
DOI: 10.1101/2021.12.22.21268237
sha: c19f2dd9bc38d4beaa9191b5254e0b2760355c47
doc_id: 325777
cord_uid: vgzbkxe5

Importance: Previous reports have suggested reductions in mortality risk from COVID-19 throughout the first wave of the COVID-19 pandemic. Mortality changes later in the pandemic and pandemic effects on other types of geriatric hospitalizations are less studied. Objectives: To describe the changes in hospitalizations and 30-day mortality in Stockholm for patients 70+ receiving inpatient geriatric care for COVID-19 and other causes. Design: Observational study. For patients 70 or older, we present the incidence of 30-day mortality from COVID-19 in the Stockholm region, in relationship to geriatric hospitalizations and 30-day mortality after admission for COVID-19 and other causes. Setting: Hospitalizations for patients 70+ from geriatric clinics in Stockholm, Sweden hospitalized for COVID-19 or other causes between March 2020 and July 31, 2021, were included. Participants: The total number of geriatric hospitalizations for patients 70+ was 5,320 for COVID-19 and 32,243 for non-COVID-19 causes, corresponding to 4,565 individual COVID-19 patients and 19,308 non-COVID-19 patients. Exposure(s): The date of hospital admission to a geriatric clinic. Main Outcome(s) and Measure(s): 30-day mortality after admission. Results: In patients with COVID-19, the 30-day mortality rate was highest at the beginning of the first wave (29% in March-April 2020), decreased as the first wave subsided (7% July-August), increased again in the second wave (17% November-December), but failed to increase as much in the third wave (11-13% March-July 2021). In non-COVID-19 geriatric patients during the same period, the 30-day mortality presented a similar trend, but with a smaller magnitude of variation (5 to 10%). The number of persons 70 or older testing positive for COVID-19 in Stockholm reached two peaks in 2020 (April and December), fell in January 2021 and then increased again in March-April 2021. Conclusions and Relevance: During the first and second waves, hospital admissions and 30-day mortality after geriatric hospitalization for COVID-19 increased in periods of high community transmission, although the mortality peak was lower in wave 2 than in wave 1. The mortality for non-COVID geriatric cases was lower and more stable but also showed an increase with the pandemic peaks.

During the first wave of the COVID-19 pandemic in Stockholm from March to July 2020, 103 mortality for COVID-19 patients hospitalized in geriatric clinics decreased over time. 1 It was 104 unclear at the time whether this was due to improved care or to patient selection of more 105 severe cases earlier in the pandemic due to higher community incidence and an overburdened 106 healthcare system. Our results from that first wave included only in-hospital mortality and did 107 not explore how care for conditions other than COVID-19 was impacted by the pandemic. 108 Age is among the strongest risk factors for COVID-19 and the infection fatality ratio after age 109 70 is substantial. 2, 3 Here, we present data on geriatric hospitalizations for other causes, including 30-day mortality from admission and compare these to the incidence 111 of COVID-19 and 30-day mortality from COVID-19 in the Stockholm region for persons 70+. 112 We aim to describe how COVID-19 peaks affected geriatric patients 70 and older hospitalized 113 both for COVID-19 and for other causes in Stockholm. 4-7 114 115 In previous reports, COVID-19 mortality in hospitalized patients in Sweden increased with 116 each pandemic wave and decreased between pandemic peaks. 8, 9 According to the Swedish 117 Board of Health and Welfare, 60-day mortality after admission with COVID-19 decreased 118 from a first-wave peak in March 2020 (25%) to a first nadir in August-September 2020 (10%), 119 then rose again but to lower levels as the second wave progressed to a peak in December 2020 120 (20%), decreasing steadily afterwards. 10 Decreasing mortality during the first pandemic wave 121 was also observed in studies from the US, 11 with subsequent increases in mortality during 122 pandemic surges. 12 A Spanish study reported that COVID-19 patients in the first wave were 123 older, with more comorbidities and higher mortality than in the second wave. 13 However, 124 information is missing on mortality trends later in the pandemic, trends in older population 125 and in geriatric patients with diagnoses other than COVID-19.

The aim of this study is to describe the changes over time in 30 day-mortality after admission 128 of patients 70 years and older, hospitalized in 9 geriatric clinics in the Stockholm region from Exposure and Outcome 147 The study exposure was the hospital admission date (March 1 st , 2020, to July 31 st , 2021). The 148 study outcome was 30-day mortality from admission. Patients were censored at death, or the 149 end of follow-up (September 10th, 2021) whichever came first. week and COVID-19 incidence and mortality in the Stockholm region. Via logistic regression 182 models, we assessed the effect of admission date on 30-day mortality, adjusted by age, sex, 183 and medical treatment. Results were reported as odds ratios (OR) and 95% confidence 184 interval (CI). Mortality rates were also compared against non-COVID-19 patients admitted to 185 the same geriatric clinics during the same period. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Thirty-day mortality was highest at the beginning of the first wave (29% in March-April 2020 210 for COVID-19; 10% for non-COVID-19), decreased as the first wave subsided (7% July-

August for COVID-19; 6% for non-COVID-19), and increased again for COVID cases in the 212 second wave (17% November-December for COVID; 7% for non-COVID). Thirty-day 213 mortality remained more stable in the third wave (11 to 13% March-July 2021 for COVID-19; 214 6% non-COVID-19) ( Table 1 ). Figure 2B shows the relationship between weekly COVID-19 hospital admissions to the nine 216 geriatric hospitals and 30-day mortality. Mortality is lowest when few COVID-19 patients are 217 hospitalized. Figure 2C presents the same relationship but for other geriatric patients. The 218 lowest mortality rates appear in the interpandemic peaks, when COVID hospitalizations were 219 lowest and non-COVID hospitalizations were highest. Figure 2 ). increase in admission rate didn't correlate with local COVID-19 incidence. Mortality risk 264 after ED visits also increased. The drop in ED visits, together with increased admission rate 265 and mortality suggest that patients were avoiding seeking care, selecting for a sicker patient 266 population in the ED. Furthermore, the lack of correlation with COVID-19 incidence suggests 267 that patient behaviours (rather than hospital capacity) were responsible. 18 Another US study 268 found a decrease in ED visits for serious cardiovascular conditions early in the pandemic with 269 gradual recovery (until October 2020) 19 . The same drop in cardiovascular visits was seen in 270 Europe. 20, 21 In contrast to the US study we saw a drop in hospitalizations in our cohort but not 271 a complete recovery afterwards. We do not have data on ED visits so we cannot distinguish 272 between patient care-seeking behaviours and triage in the ED. As seen in figure Second, 30-day mortality rose and fell with the pandemic waves. However, the peak mortality 278 in geriatric clinics was higher in the first than in the second wave. This effect was more 279 evident for COVID-19 patients but appeared also in non-COVID geriatric patients. Several 280 studies, including our previous study, have noted a decrease in mortality throughout the first 281 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 27, 2021. ;  wave of the pandemic 22 1 . A subsequent increase was observed again during the second wave 282 in Sweden 9, 23 . One study included more than 30,000 COVID-19 patients (including those 283 admitted to the ICU) hospitalized between March and December 2020 in Sweden and showed 284 that the 60-day case fatality rate for hospitalized cases decreased in the first wave but 285 increased again in the second wave 9 . This study noted that the average age and comorbidities 286 for hospitalized patients increased in the second wave, although they adjusted for these and 287 other factors. 288 289 COVID-19 incidence was more severely underreported in the first wave in Sweden than later 290 in the pandemic. 23 Some patients were treated in their nursing homes and never transferred to 291 hospital, and this could have the effect of lowering the average age and comorbidities in the 292 first wave but, interestingly, this change in average age is not present in our cohort. This may 293 be explained by the fact that most patients admitted to inpatient geriatric hospital care lived in 294 their own homes prior to admission. In this geriatric cohort, the proportion of patients 295 presenting with oxygen saturation under 90% at baseline decreased from 8.9% in March-April 296 2020 to 2% in June, increasing again to 7.7% in December 2020. In our previous article we 297 showed that low oxygen saturation at baseline explained some, but not all, of the temporal 298 trend in mortality observed during the first wave. 1 Triage was probably harsher in the first 299 wave leading to a sicker patient population and higher mortality. The alpha variant arrived in 300 Sweden in December 2020, too late to explain the increase in 30-day mortality. Improvements 301 in treatment may also explain a part of the reduction in mortality.

In an international context, studies from Africa 24 , Italy 25 , and Germany 26 showed a significant 304 difference in COVID-mortality between the first wave and the second wave. Our temporal 305 trend closely follows the German report, with high initial case fatal ratio, nadir in summer 306 2020 and subsequent increase in the second wave. In Germany, the first wave was smaller 307 and led to fewer hospitalizations than the second, while the peaks in hospitalizations between 308 the waves were more similar in Sweden. Despite this, the highest mortality in both studies 309 was seen in the initial peak of the first wave 26 . Another study examined raw case fatality ratio wave. In the second wave, the national guidelines for COVID-19 patients hospitalized in 328 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 27, 2021. ;

Sweden didn't undergo major changes. In a previous report, we have shown that the prognosis 329 of COVID-19 for the most frail during the first wave was ominous 29 . It is possible that the 330 most vulnerable and frail died during the first wave and thus contributing to lower mortality 331 during the second wave. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 27, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 27, 2021. ; 

LMWH, low-molecular-weight heparin; NOAC, Non-vitamin-K antagonist oral anticoagulant.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted December 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint 

Decreased Mortality Over Time During the 393

First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study

A scaling approach to estimate the age-dependent COVID-19 infection 396 fatality ratio from incomplete data

Estimating the infection and case fatality ratio 399 for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond 400 Princess cruise ship

Dexamethasone in Hospitalized Patients with 403

The New England journal of medicine

Remdesivir for the Treatment of Covid-19 -406 Final Report. The New England journal of medicine

Preliminary Experience With Low 408

Molecular Weight Heparin Strategy in COVID-19 Patients

Remdesivir in adults with severe COVID-19: a 411 randomised, double-blind, placebo-controlled, multicentre trial

Mortality trends among hospitalised COVID-19 414 patients in Sweden: A nationwide observational cohort study. Lancet Reg Health Eur

Second wave mortality among patients 417 hospitalised for COVID-19 in Sweden: a nationwide observational cohort study

Hospitalization and mortality trends among 423 patients with confirmed COVID-19 in the United States

Hospital Mortality Among Hospitalized COVID-19 Patients in the United States

Changes in severity, mortality, and 429 virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2. Sci Rep

Hospital length of stay for COVID-19 patients: 432 Data-driven methods for forward planning